Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage

Biomedical Chromatography

Volumn 27, Issue 11, 2013, Pages 1489-1496

  Fortuna, Serena ^a   De Pascale, Gennaro ^a   Ragazzoni, Enzo ^a   Antonelli, Massimo ^a   Navarra, Pierluigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

BAL; HPLC UV; Linezolid; Solid phase extraction; Therapeutic drug monitoring

Indexed keywords

EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT MONITORING; PLASMA (HUMAN);

BRONCHOALVEOLAR LAVAGE; CHROMATOGRAPHIC SEPARATIONS; HPLC-UV; HUMAN PLASMAS; ISOCRATIC MOBILE PHASE; LINEZOLID; MOBILE PHASE SOLUTION; PLASMA SAMPLES; SOLID-PHASE EXTRACTION; THERAPEUTIC DRUG MONITORING;

PHASE SEPARATION;

ANTIBIOTIC AGENT; LINEZOLID;

ACCURACY; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CONTINUOUS INFUSION; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG LAVAGE; MASS SPECTROMETRY; MULTIDRUG RESISTANCE; PLASMA; QUANTITATIVE ANALYSIS; SEPTIC SHOCK; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION;

BAL; HPLC-UV; LINEZOLID; SOLID-PHASE EXTRACTION; THERAPEUTIC DRUG MONITORING;

ACETAMIDES; ANTI-INFECTIVE AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; LIMIT OF DETECTION; OXAZOLIDINONES; SOLID PHASE EXTRACTION; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS;

EID: 84885922173     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2947     Document Type: Article

References (27)

1. Abdel-Rehim M. New trend in sample preparation: on-line microextraction in packed syringe for liquid and gas chromatography applications. I. Determination of local anaesthetics in human plasma samples using gas chromatography-mass spectrometry. Journal of Chromatography B 2004; 801(2): 317-321.
2. Adembri C, Fallani S, Cassetta MI, Arrigucci S, Ottaviano A, Pecile P, Mazzei T, De Gaudio R and Novelli A. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. International Journal of Antimicrobial Agents 2008; 31(2): 122-129.
3. Ba BB, Nso BB, Quentin C and Saux MC. Determination of linezolid in growth media by high-performance liquid chromatography with on-line extraction. Journal of Chromatography B 2007; 854(1-2): 104-108.
4. Baietto L, D'Avolio A, De Rosa FG, Garazzino S, Patanella S, Siccardi M, Sciandra M and Di Perri G. Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. Therapeutic Drug Monitoring 2009; 31(1): 104-109.
5. Boselli E, Breilh D, Rimmelé T, Djabarouti S, Toutain J, Chassard D, Saux MC and Allaouchiche B. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia. Critical Care Medicine 2005; 33(7): 1529-1533.
6. Boselli E, Breilh D, Caillault-Sergent A, Djabarouti S, Guillaume C, Xuereb F, Bouvet L, Rimmelé T, Saux MC and Allaouchiche B. Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia. The Journal of Antimicrobial Chemotherapy 2012; 67(5): 1207-1210.
7. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B and Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical Infectious Disease 2009; 48(1): 1-12.
8. Buerger C, Joukhadar C, Muller M and Kloft C. Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples. Journal of Chromatography B 2003; 796(1): 155-164.
9. Cattaneo D, Baldelli S, Conti F, Cozzi V and Clementi E. Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection. Therapeutic Drug Monitoring 2010; 32(4): 520-524.
10. Colin P, De Bock L, T'jollyn H, Boussery K and Van Bocxlaer J. Development and validation of a fast and uniform approach to quantify b-lactam antiobiotics in human plasma by solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry. Talanta 2013; 103: 285-293.
11. Conte JE, Golden JA, Kipps J and Zurlinden E. Intrapulmonary pharmacokinetics of linezolid. Antimicrobial Agents and Chemotherapy 2002; 46(5): 1475-1480.
12. De Pascale G, Fortuna S, Navarra P and Antonelli M. Linezolid use in ventilator-associated pneumonia: look at the body weight of your patients! Minerva Anestesiologica 2012; 78: 1418-1419.
13. Dryden MS. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. The Journal of Antimicrobial Chemotherapy 2011; 66(suppl. 4): iv7-iv15.
14. Ehrlich M, Trittler R, Daschner FD and Kummerer K. A new and rapid method for monitoring the new oxazolidinone antibiotic linezolid in serum and urine by high performance liquid chromatography-integrated sample preparation. Journal of Chromatography B 2001; 755(1-2): 373-377.
15. Ibrahim EH, Sherman G, Ward S, Fraser VJ and Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118(1): 146-155.
16. Iregui M, Ward S, Sherman G, Fraser VJ and Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122(1): 262-268.
17. Pea F and Viale P. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Clinical Infectious Disease 2006; 42(12): 1764-1771.
18. Pea F, Furlanut M, Cojutti P, Cristini F, Zamparini E, Franceschi L and Viale P. Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. Antimicrobial Agents and Chemotherapy 2010; 54(11): 4605-4610.
19. Pea F, Viale P, Cojutti P, Del Pin B, Zamparini E and Furlanut M. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. The Journal of Antimicrobial Chemotherapy 2012; 67(8): 2034-2042.
20. Peng GW, Stryd RP, Murata S, Igarashi M, Chiba K, Aoyama H, Aoyama M, Zenki T and Ozawa N. Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 1999; 20(1-2): 65-73.
21. Phillips OA, Abdel-Hamid ME and al-Hassawi NA. Determination of linezolid in human plasma by LC-MS-MS. The Analyst 2001; 126(5): 609-614.
22. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG and Crystal RG. Estimation of volume of epithelial lining fluid recovered by lavage urea as marker of dilution. Journal of Applied Physiology 1986; 60(2): 532-538.
23. Ross JE, Farrell DJ, Mendes RE, Sader HS and Jones RN. Eight-year (2002-2009) summary of the linezolid (Zyvox® Annual Appraisal of Potency and Spectrum; ZAAPS) program in European countries. Journal of Chemotherapy 2011; 23(2): 71-76.
24. Szultka M, Krzeminski R, Szeliga J, Jackowski M and Buszewski B. A new approach for antibiotics drugs determination in human plasma by liquid chromatography-mass spectrometry. Journal of Chromatography. A 2013; 1272: 41-49.
25. Tobin CM, Sunderland J, White LO and MacGowan AP. A simple, isocratic high-performance liquid chromatography assay for linezolid in human serum. The Journal of Antimicrobial Chemotherapy 2001; 48(5): 605-608.
26. Traunmuller F, Mauric O, Popovic M and Joukhadar C. Rapid and sensitive determination of the antibiotic linezolid in low plasma volumes by high-performance liquid chromatography. Journal of Chromatographic Science 2010; 48(5): 325-327.
27. US Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, MD, 2001. Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf (accessed 18 February 2013).